Isenolic (Olive Leaf Extract)

Olive leaf extract contains oleuropein as its primary bioactive compound, which exerts antiviral effects by inhibiting neuraminidase enzymes critical to viral replication and spread. Standardized formulations have demonstrated dose-dependent suppression of influenza A (H3N2) activity in laboratory models, positioning it as a candidate immune support ingredient.

Origin & History

Isenolic is a branded olive leaf extract (Olea europaea) standardized to ≥4% elenolic acid by HPLC, with formulations up to 8% EA dry basis. Produced by Pharmactive Biotech Products S.L. via a proprietary extraction process, it contains secoiridoids derived from oleuropein hydrolysis.

Historical & Cultural Context

No traditional use information for Isenolic specifically was provided in the research, as it is a modern branded extract. While olive leaf (Olea europaea) has traditional uses, specific historical context for this standardized extract is absent from available sources.

Health Benefits

• Antiviral activity against influenza A (H3N2) through neuraminidase inhibition (preliminary evidence from in vitro studies)
• Dose-dependent viral replication inhibition with IC50 of 65.5 µg/ml for 8% EA formulation (in vitro evidence)
• Cell viability preservation under viral infection conditions (CC50 149.7 µg/ml, in vitro data)
• Multi-target antiviral mechanisms including blocking viral entry and replication (in vitro studies only)
• Potential immune support through stimulation of phagocytosis (preliminary in vitro evidence)

How It Works

Oleuropein and its metabolite elenolic acid inhibit viral neuraminidase, the enzyme influenza A uses to cleave sialic acid residues and release newly formed virions from host cells, effectively trapping the virus and limiting spread. An 8% elenolic acid (EA) standardized formulation achieved an IC50 of 65.5 µg/ml in vitro, indicating potent dose-dependent neuraminidase inhibition. Oleuropein also appears to modulate NF-κB signaling pathways, contributing to reduced inflammatory cytokine expression during viral challenge.

Scientific Research

Evidence is limited to in vitro studies with no human clinical trials identified. One key study (PMC8641117) tested Isenolic on MDCK-SIAT1 cells infected with influenza A (H3N2), showing the 8% EA formulation had superior neuraminidase inhibition compared to 4% EA (IC50 65.5 µg/ml vs. 171.4 µg/ml; P<0.01).

Clinical Summary

Current evidence for Isenolic olive leaf extract's antiviral effects is limited to in vitro (cell-based) studies, with no published human randomized controlled trials specifically evaluating this standardized formulation for influenza. The in vitro data demonstrated an IC50 of 65.5 µg/ml for neuraminidase inhibition using an 8% elenolic acid formulation, with measurable preservation of host cell viability under H3N2 viral infection conditions. While broader olive leaf extract research includes small human trials on blood pressure and oxidative stress markers, direct extrapolation to antiviral immune support requires caution. The evidence base is preliminary and promising but insufficient to draw definitive clinical conclusions without controlled human trials.

Nutritional Profile

{"bioactive_compounds": {"oleuropein": "20-25% of extract", "hydroxytyrosol": "1-2% of extract", "tyrosol": "0.5-1% of extract", "flavonoids": "0.5-1% of extract"}, "macronutrients": {"fiber": "Negligible", "protein": "Negligible", "fat": "Negligible", "carbohydrates": "Negligible"}, "micronutrients": {"vitamins": "Negligible", "minerals": "Negligible"}, "bioavailability_notes": "Oleuropein and hydroxytyrosol are the primary bioactive compounds with moderate bioavailability. The presence of other polyphenols may enhance absorption."}

Preparation & Dosage

No human dosage ranges have been established. In vitro studies used 6-150 µg/ml concentrations in cell culture, with optimal activity at IC50 of 65.5 µg/ml for 8% EA formulation. Standardization is 4% or 8% elenolic acid by HPLC. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Vitamin D3, Zinc, Elderberry Extract, Quercetin

Safety & Interactions

Olive leaf extract is generally well tolerated at typical supplemental doses (500–1000 mg/day of standardized extract), with the most commonly reported side effect being mild gastrointestinal discomfort including nausea or stomach cramping. Oleuropein may potentiate the effects of antihypertensive medications and anticoagulants such as warfarin due to its vasodilatory and platelet-modulating properties, requiring caution in patients on these drugs. Individuals taking antidiabetic medications should monitor blood glucose closely, as olive leaf extract has demonstrated hypoglycemic activity in preclinical models. Safety data during pregnancy and lactation is insufficient, so use is not recommended in these populations without medical supervision.